Article
Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia.
Blood - 13 Aug 2009
Ansari Marc, Sauty Géraldine, Labuda Malgorzata, Gagné Vincent, Laverdière Caroline, Moghrabi Albert, Sinnett Daniel, Krajinovic Maja
Abstract excerpt
Methotrexate and 6-mercaptopurine, important components of acute lymphoblastic leukemia treatment, are substrates for multidrug resistance-associated protein MRP4. Eight single nucleotide polymorphisms were analyzed in MRP4 gene, and 4 variants were identified as tagSNPs with frequency more than or equal to 5%. They were investigated for association with treatment responses in 275 children with acute...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
